💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
![]() |
@raygachette I love orphan drugs Shoutout to $ALXN $VRTX for the last 10 years https://t.co/kTYV6BIRzG May 13th 2022, 1:05pm |
![]() |
@BiotechElmo Anti-complement for SCD VOC? Cool nonclinical work from $ALXN / $AZD at EHA with ALXN1820 (anti-properdin)… https://t.co/yZtbekDcBs May 12th 2022, 8:05pm |
![]() |
@Sports_bios I agree the $ALXN pkg had the secondaries all went +ve and supportive and the $ALMX pkg lacked that supportive evid… https://t.co/kYzG5ml2jm May 8th 2022, 9:05pm |
![]() |
@AntounNabhan RT @BertrandBio: Ultomiris $AZN $ALXN met primary endpoint in CHAMPION-NMOSD Phase III trial in adults with neuromyelitis optica spectrum d… May 5th 2022, 8:05am |
![]() |
@BertrandBio Ultomiris $AZN $ALXN met primary endpoint in CHAMPION-NMOSD Phase III trial in adults with neuromyelitis optica spe… https://t.co/TlsCVLbMch May 5th 2022, 8:05am |
![]() |
@BertrandBio $AZN $ALXN on conversion from Soliris to Ultomiris in gMG (lower annual costs but reaching more pts) https://t.co/2RdLXLmvXW April 29th 2022, 11:04am |
![]() |
@BertrandBio In these times of layoffs: AstraZeneca $AZN announces plans for new strategic R&D centre and Alexion $ALXN headqua… https://t.co/7lZCzQ8icq April 29th 2022, 11:04am |
![]() |
@Gambiste1 RT @BertrandBio: $AZN also looking good after $ALXN integration & COVID contributions, but apparently just in line with the expectations re… April 29th 2022, 10:04am |
![]() |
@BertrandBio $AZN also looking good after $ALXN integration & COVID contributions, but apparently just in line with the expectat… https://t.co/RuzGS1ZQlp April 29th 2022, 9:04am |
![]() |
@vtmtrading Compass Therapeutics appoints Ellen Chiniara, Mary Ann Gray to board $CMPX $ALXN April 26th 2022, 12:04pm |
![]() |
@Buck_Fiotech I can hear the dipshit Biocrusties now- in complete disbelief, “but I thought this was gonna b the next $alxn “- su… https://t.co/o1jHBmubFv April 14th 2022, 10:04pm |
![]() |
@newsfilterio Alexion Pharmaceuticals expects to exceed top end of revenue guidance $ALXN https://t.co/uZ8VgkttxG April 14th 2022, 5:04am |
![]() |
@Buck_Fiotech Biocrusties a lil but hurt- ouch! Is $bcrx still gonna b the next $alxn ? If u didn’t take ur gain when this overva… https://t.co/PvizC0Q6T6 April 12th 2022, 11:04pm |
![]() |
@AmyAtrrade RT @AmyAtrade: $ALXN Long setup https://t.co/GSV7zBssJ1 April 12th 2022, 7:04pm |
![]() |
@AmyAtrrade RT @AmyAtrade: $ALXN Look very nice on Yearly chart but need to setup on lower time frames, adding to my watchlist, https://t.co/2Vsqq8eiA8 April 12th 2022, 7:04pm |
![]() |
@newsfilterio A Study of ALXN1840 Administered With And Without Omeprazole In Healthy Adults - NCT05319912 $ALXN https://t.co/qfIXRTjV0g April 8th 2022, 7:04pm |
![]() |
@newsfilterio A Study of ALXN1840 Administered With And Without Omeprazole In Healthy Adults - NCT05319899 $ALXN https://t.co/EEZ5h8oaEg April 8th 2022, 7:04pm |
![]() |
@BertrandBio $AZN $ALXN ULTOMIRIS® (ravulizumab-cwvz) demonstrated sustained improvements in functional activities and quality o… https://t.co/1nkvwX14mu April 6th 2022, 11:04am |
![]() |
@newsfilterio A Study of a Single Subcutaneous Dose of ALXN1210 in Healthy Adult Participants - NCT05288829 $ALXN https://t.co/MTyX8Wk089 March 22nd 2022, 5:03am |
![]() |
@newsfilterio A Study of Single and Multiple Doses of ALXN1210 in Healthy, Adult Japanese Participants - NCT05288816 $ALXN https://t.co/eIymib1dkr March 22nd 2022, 5:03am |
![]() |
@newsfilterio A Study of Multiple Doses of ALXN1210 in Healthy Adult Participants - NCT05288673 $ALXN https://t.co/JhxrYg2f3l March 22nd 2022, 5:03am |
![]() |
@newsfilterio A Study of a Single Dose of ALXN1210 in Healthy Participants - NCT05288660 $ALXN https://t.co/JDqfzHKNuW March 22nd 2022, 5:03am |
![]() |
@Gambiste1 RT @PredatorDiaries: When $AZN bought $ALXN https://t.co/9r1yv8tgW5 March 17th 2022, 10:03am |
![]() |
@PredatorDiaries When $AZN bought $ALXN https://t.co/9r1yv8tgW5 March 17th 2022, 9:03am |
![]() |
@BertrandBio 775m$ to be added to the consideration for $ALXN consideration (payment to Chugai) AstraZeneca reaches settlement… https://t.co/B5m8Edqwde March 17th 2022, 8:03am |
![]() |
@AngelaHart249 $ALXN ~If you really want to make huge profits on trading then check out this chat: https://t.co/4wmXzVQdSV March 16th 2022, 8:03am |
![]() |
@bthefirsttoknow First out// $ALXN: Wilson Disease Drugs Market Analysis Growth Challenges, Opportunities and Future Developments to… https://t.co/uqcl2xhxh2 March 13th 2022, 10:03am |
![]() |
@NithyaSunita $ALXN Best room on the net,.. Stay turned: https://t.co/4Aw0Pxoed4 March 3rd 2022, 1:03am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.